NCPA


Driving Up Prices

The increasing number of lawsuits against makers of the diphtheria, pertussis (whooping cough) and tetanus (DPT) vaccine has driven up its price throughout the 1970s and 1980s.

Throughout the 1950s and 1960s, the wholesale price of the DPT vaccine was virtually the same as the wholesale price of the DT vaccine, which protects against diphtheria and tetanus but has no pertussis component. This strongly suggests that it cost little or nothing to manufacture the pertussis component.

But a limited number of children given the vaccine with the pertussis component - between 1 in 310,000 and 1 in 480,000 - experience a serious neurological reaction that has long-term con-sequences.

In the late 1970s, changes in liability laws allowed injured consumers to sue DPT producers. As lawsuits were filed, the price of DPT vaccine shot up while the price of DT stayed level.

Based on the increase in price, for every $1 of compensation transferred to injured consumers DPT producers expected to spend at least $5 and as much as $22 on legal expenses plus compensation.

The increased risk of lawsuits also drove DPT producers from the market. There were 10 DPT producers in 1954 and six in 1979. By 1989, there were only two. - David R. Henderson.

Source: Richard L. Manning, "Changing Rules in Tort Law and the Market for Childhood Vaccines," Journal of Law and Economics, Vol. 37, April 1994.


Home | Support Us | All Issues | Social Security | Debate Central | Contact Us

Dallas Headquarters: 12770 Coit Rd., Suite 800 - Dallas, TX 75251-1339 - 972/386-6272 - Fax 972/386-0924
Washington Office: 601 Pennsylvania Avenue NW, Suite 900 South Building, Washington, DC 20004 - 202/220-3082 - Fax 202/220-3096
© 2001 NCPA